Dr. Freeman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
95 Madison Ave
Morristown, NJ 07960Phone+1 973-538-5210Fax+1 973-644-9657
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011
Beth Israel Deaconess Medical CenterResidency, Surgery, 2005 - 2008- Rutgers New Jersey Medical SchoolClass of 2005
Certifications & Licensure
NJ State Medical License 2014 - 2025
MA State Medical License 2011 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery.Jennifer Ma, Luke Del Balzo, Henry Walch, Sari Khaleel, Andrea Knezevic
European Urology Oncology. 2024-08-05 - Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.Linlin Xu, Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan Porter
Haematologica. 2024-07-01 - 35 citationsZanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke
The Lancet. Haematology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
